These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 11006733)

  • 1. [Drug therapy of patients with emotionally unstable personality].
    Nissen T
    Tidsskr Nor Laegeforen; 2000 Aug; 120(18):2135-41. PubMed ID: 11006733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacological treatment of borderline personality disorders. Several options for symptom reduction but nothing for the disorder per se].
    Rydén G; Vinnars B
    Lakartidningen; 2002 Dec; 99(50):5088-94. PubMed ID: 12572301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The value of psychopharmacotherapy in the treatment of borderline personality disorder].
    Leitner P; Serfling R
    Psychiatr Prax; 1993 Nov; 20(6):207-10. PubMed ID: 7906044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms.
    Mercer D; Douglass AB; Links PS
    J Pers Disord; 2009 Apr; 23(2):156-74. PubMed ID: 19379093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy of personality disorders: conceptual framework and clinical strategies.
    Gitlin MJ
    J Clin Psychopharmacol; 1993 Oct; 13(5):343-53. PubMed ID: 8227492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotics, antidepressants, anticonvulsants, and placebo on the symptom dimensions of borderline personality disorder: a meta-analysis of randomized controlled and open-label trials.
    Vita A; De Peri L; Sacchetti E
    J Clin Psychopharmacol; 2011 Oct; 31(5):613-24. PubMed ID: 21869691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trials.
    Nosè M; Cipriani A; Biancosino B; Grassi L; Barbui C
    Int Clin Psychopharmacol; 2006 Nov; 21(6):345-53. PubMed ID: 17012981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effectiveness of antipsychotics in borderline personality disorder: meta-analyses of placebo-controlled, randomized clinical trials on symptomatic outcome domains.
    Ingenhoven TJ; Duivenvoorden HJ
    J Clin Psychopharmacol; 2011 Aug; 31(4):489-96. PubMed ID: 21694626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy of borderline states.
    Brinkley JR
    Psychiatr Clin North Am; 1993 Dec; 16(4):853-84. PubMed ID: 7906031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychopharmacology of borderline personality disorder.
    Soloff PH
    Psychiatr Clin North Am; 2000 Mar; 23(1):169-92, ix. PubMed ID: 10729938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological treatment of borderline personality disorder].
    Mazaira S
    Vertex; 2004 Dec-2005 Feb; 15(58):303-8. PubMed ID: 15597127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug treatment of obsessive-compulsive disorder: a review of findings in the light of diagnostic and metric limitations.
    Towbin KE; Leckman JF; Cohen DJ
    Psychiatr Dev; 1987; 5(1):25-50. PubMed ID: 2885832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy for personality disorders.
    Hori A
    Psychiatry Clin Neurosci; 1998 Feb; 52(1):13-9. PubMed ID: 9682928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A naturalistic study of changes in pharmacological prescription for borderline personality disorder in clinical practice: from APA to NICE guidelines.
    Pascual JC; Martín-Blanco A; Soler J; Ferrer A; Tiana T; Alvarez E; Pérez V
    Int Clin Psychopharmacol; 2010 Nov; 25(6):349-55. PubMed ID: 20838221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology, risk factors, and psychopharmacological management of suicidal behavior in borderline personality disorder.
    Kolla NJ; Eisenberg H; Links PS
    Arch Suicide Res; 2008; 12(1):1-19. PubMed ID: 18240030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Symptom-focussed drug therapy in borderline personality disorder].
    Schmahl C; Bohus M
    Fortschr Neurol Psychiatr; 2001 Jul; 69(7):310-21. PubMed ID: 11488246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychopharmacologic approaches to the borderline patient.
    Zisook S; Ricketts JE
    Hillside J Clin Psychiatry; 1988; 10(1):55-70. PubMed ID: 2900799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preliminary trial of fluoxetine in refractory borderline patients.
    Cornelius JR; Soloff PH; Perel JM; Ulrich RF
    J Clin Psychopharmacol; 1991 Apr; 11(2):116-20. PubMed ID: 2056138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.